| 000 | 01909 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514062804.0 | ||
| 264 | 0 | _c20030620 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.2003.02098.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEngstrand, M | |
| 245 | 0 | 0 |
_aCellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cApr 2003 |
||
| 300 |
_a96-104 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aADP-ribosyl Cyclase _xanalysis |
| 650 | 0 | 4 | _aADP-ribosyl Cyclase 1 |
| 650 | 0 | 4 |
_aAntigens, CD _xanalysis |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _xanalysis |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aCytomegalovirus _xphysiology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _ximmunology |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aInterferon-gamma _ximmunology |
| 650 | 0 | 4 | _aLectins, C-Type |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aOrgan Transplantation |
| 650 | 0 | 4 |
_aPhosphoproteins _xanalysis |
| 650 | 0 | 4 |
_aViral Matrix Proteins _xanalysis |
| 650 | 0 | 4 | _aVirus Latency |
| 700 | 1 | _aLidehall, A K | |
| 700 | 1 | _aTotterman, T H | |
| 700 | 1 | _aHerrman, B | |
| 700 | 1 | _aEriksson, B-M | |
| 700 | 1 | _aKorsgren, O | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 132 _gno. 1 _gp. 96-104 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.2003.02098.x _zAvailable from publisher's website |
| 999 |
_c12447701 _d12447701 |
||